Lithium carbonate in pALS with UNC13A variation

The MAGNET study is an innovative clinical research platform investigating multiple potential ALS medicines simultaneously. This
approach will significantly enhance the number of patients that can participate. Besides, the burden of participants is minimised while
the chance of finding effective ALS medicines is maximised.
The first arm of the MAGNET study has started, studying lithium
carbonate in ALS-patients with an UNC13A variation.
All information on the study an be found here at the TRICALS website.